BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 25349228)

  • 1. A cost-effectiveness analysis of screening for silent atrial fibrillation after ischaemic stroke.
    Levin LÅ; Husberg M; Sobocinski PD; Kull VF; Friberg L; Rosenqvist M; Davidson T
    Europace; 2015 Feb; 17(2):207-14. PubMed ID: 25349228
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cost-effectiveness of screening for atrial fibrillation in primary care with a handheld, single-lead electrocardiogram device in the Netherlands.
    Jacobs MS; Kaasenbrood F; Postma MJ; van Hulst M; Tieleman RG
    Europace; 2018 Jan; 20(1):12-18. PubMed ID: 27733465
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of mass screening for untreated atrial fibrillation using intermittent ECG recording.
    Aronsson M; Svennberg E; Rosenqvist M; Engdahl J; Al-Khalili F; Friberg L; Frykman-Kull V; Levin LÅ
    Europace; 2015 Jul; 17(7):1023-9. PubMed ID: 25868469
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of a community-based screening programme for chronic atrial fibrillation in Japan.
    Maeda K; Shimbo T; Fukui T
    J Med Screen; 2004; 11(2):97-102. PubMed ID: 15153326
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Potential Cost-Effectiveness of Ambulatory Cardiac Rhythm Monitoring After Cryptogenic Stroke.
    Yong JH; Thavorn K; Hoch JS; Mamdani M; Thorpe KE; Dorian P; Sharma M; Laupacis A; Gladstone DJ;
    Stroke; 2016 Sep; 47(9):2380-5. PubMed ID: 27470989
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Improved screening for silent atrial fibrillation after ischaemic stroke.
    Doliwa Sobocinski P; Anggårdh Rooth E; Frykman Kull V; von Arbin M; Wallén H; Rosenqvist M
    Europace; 2012 Aug; 14(8):1112-6. PubMed ID: 22308086
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cost-effectiveness and screening performance of ECG handheld machine in a population screening programme: The Belgian Heart Rhythm Week screening programme.
    Proietti M; Farcomeni A; Goethals P; Scavee C; Vijgen J; Blankoff I; Vandekerckhove Y; Lip GY; Mairesse GH;
    Eur J Prev Cardiol; 2019 Jun; 26(9):964-972. PubMed ID: 30935219
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Feasibility and cost-effectiveness of stroke prevention through community screening for atrial fibrillation using iPhone ECG in pharmacies. The SEARCH-AF study.
    Lowres N; Neubeck L; Salkeld G; Krass I; McLachlan AJ; Redfern J; Bennett AA; Briffa T; Bauman A; Martinez C; Wallenhorst C; Lau JK; Brieger DB; Sy RW; Freedman SB
    Thromb Haemost; 2014 Jun; 111(6):1167-76. PubMed ID: 24687081
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of dabigatran versus vitamin K antagonists for the prevention of stroke in patients with atrial fibrillation: a French payer perspective.
    Chevalier J; Delaitre O; Hammès F; de Pouvourville G
    Arch Cardiovasc Dis; 2014; 107(6-7):381-90. PubMed ID: 24973113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cost-effectiveness of 7-day-Holter monitoring alone or in combination with transthoracic echocardiography in patients with cerebral ischemia.
    Mayer F; Stahrenberg R; Gröschel K; Mostardt S; Biermann J; Edelmann F; Liman J; Wasem J; Goehler A; Wachter R; Neumann A
    Clin Res Cardiol; 2013 Dec; 102(12):875-84. PubMed ID: 23904073
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of insertable cardiac monitors for the detection of atrial fibrillation in patients with cryptogenic stroke in the United States is cost-effective.
    Maervoet J; Bossers N; Borge RP; Hilpert ST; van Engen A; Smala A
    J Med Econ; 2019 Nov; 22(11):1221-1234. PubMed ID: 31480905
    [No Abstract]   [Full Text] [Related]  

  • 12. Cost-effectiveness of dabigatran compared with warfarin for patients with atrial fibrillation in Sweden.
    Davidson T; Husberg M; Janzon M; Oldgren J; Levin LÅ
    Eur Heart J; 2013 Jan; 34(3):177-83. PubMed ID: 22733833
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A randomised controlled trial and cost-effectiveness study of systematic screening (targeted and total population screening) versus routine practice for the detection of atrial fibrillation in people aged 65 and over. The SAFE study.
    Hobbs FD; Fitzmaurice DA; Mant J; Murray E; Jowett S; Bryan S; Raftery J; Davies M; Lip G
    Health Technol Assess; 2005 Oct; 9(40):iii-iv, ix-x, 1-74. PubMed ID: 16202350
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Detection of Atrial Fibrillation with Intermittent Handheld Electrocardiogram in Patients with Ischemic Stroke and Transient Ischemic Attack.
    Olsson AS; Engdahl J
    J Stroke Cerebrovasc Dis; 2016 Nov; 25(11):2648-2652. PubMed ID: 27492946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-Effectiveness of a National Opportunistic Screening Program for Atrial Fibrillation in Ireland.
    Moran PS; Teljeur C; Harrington P; Smith SM; Smyth B; Harbison J; Normand C; Ryan M
    Value Health; 2016 Dec; 19(8):985-995. PubMed ID: 27987649
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cost-effectiveness of dabigatran compared with warfarin for stroke prevention in atrial fibrillation.
    Freeman JV; Zhu RP; Owens DK; Garber AM; Hutton DW; Go AS; Wang PJ; Turakhia MP
    Ann Intern Med; 2011 Jan; 154(1):1-11. PubMed ID: 21041570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cost-effectiveness of outpatient cardiac monitoring to detect atrial fibrillation after ischemic stroke.
    Kamel H; Hegde M; Johnson DR; Gage BF; Johnston SC
    Stroke; 2010 Jul; 41(7):1514-20. PubMed ID: 20508188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cost-effectiveness of apixaban compared with aspirin for stroke prevention in atrial fibrillation among patients unsuitable for warfarin.
    Lee S; Anglade MW; Meng J; Hagstrom K; Kluger J; Coleman CI
    Circ Cardiovasc Qual Outcomes; 2012 Jul; 5(4):472-9. PubMed ID: 22740012
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cost-Effectiveness of Extended Electrocardiogram Monitoring for Atrial Fibrillation After Stroke: A Systematic Review.
    Chew DS; Rennert-May E; Spackman E; Mark DB; Exner DV
    Stroke; 2020 Jul; 51(7):2244-2248. PubMed ID: 32498661
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cost-effectiveness of clopidogrel plus aspirin for stroke prevention in patients with atrial fibrillation in whom warfarin is unsuitable.
    Coleman CI; Straznitskas AD; Sobieraj DM; Kluger J; Anglade MW
    Am J Cardiol; 2012 Apr; 109(7):1020-5. PubMed ID: 22221944
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.